Incurin is a veterinary medicine used for the treatment of hormone-dependent urinary incontinence resulting from sphincter mechanism incompetence (SMI) in ovariohysterectomised bitches (i.e. in dogs having had the ovaries and uterus removed surgically). Incurin contains the active substance estriol.
Incurin : EPAR - Summary for the public (PDF/117.79 KB)
First published: 06/06/2008
Last updated: 24/02/2021
|Agency product number||
|International non-proprietary name (INN) or common name||
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
Intervet International BV
|Date of issue of marketing authorisation valid throughout the European Union||
Intervet International B.V.
Wim de Körverstraat 35
5831 AN Boxmeer
30/08/2014 Incurin - EMEA/V/C/000047 - IA/0006/G
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Sex hormones and modulators of the genital system
The treatment of hormone-dependent urinary incontinence due to sphincter mechanism incompetence in ovariohysterectomised bitches.